Multinationals willing to expand direct transactions with wholesalers

Published: 2007-06-15 07:00:00

Updated: 2007-06-15 07:00:00

17 multinational drug manufacturers, including Novartis Korea, GlaxoSmithKline, Lilly Korea, Boehringer Ingelheim Korea, Sanofi-Aventis Korea and Pfizer Korea, agreed to address the sensitive Zuellig issue in a meeting on June 13, which was arranged by the Korea Pharmaceutical Wholesalers Associa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK